Tecentriq 1 200 mg concentrate for solution for infusion, Pulmocis 2 mg trousse pour préparation radiopharmaceutique, Avastin 25 mg/ml concentrate for solution for infusion.
2021/3330 HOLMBRAVE
Phase 2 small_molecule active
Quick answer
Tecentriq 1 200 mg concentrate for solution for infusion, Pulmocis 2 mg trousse pour préparation radiopharmaceutique, Avastin 25 mg/ml concentrate for solution for infusion. for Non resectable Hepatocellular carcinoma (HCC) is a Phase 2 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Non resectable Hepatocellular carcinoma (HCC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active